Bigmar Files Form 10-KSB and Announces Date of 1999 Annual Meeting of Shareholders.Business Editors JOHNSTOWN, Ohio--(BW HealthWire)--March 31, 2000 Bigmar Inc. (Nasdaq:BGMR BGMR Bigmar Inc. (stock symbol) ) today announced that its annual report on Form 10-KSB for the year ended Dec. 31, 1999, has been filed with the Securities and Exchange Commission and copies are available upon request. In addition, the company announced that its 1999 annual meeting of shareholders will take place on Friday, June 9, 2000, at the company's headquarters. On or before May 8, 2000, Bigmar expects to mail copies of its proxy statement Proxy Statement A document containing the information that a company is required by the SEC to provide to shareholders so they can make informed decisions about matters that will be brought up at an annual stockholder meeting. for its annual meeting of shareholders to all stockholders of record as of April 24, 2000. Bigmar is a manufacturer of generic pharmaceutical oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors. on·col·o·gy n. products and intravenous infusion solutions, which it manufactures at its state-of-the-art facilities in Switzerland. The company markets its products through partnerships of pharmaceutical distributors in Europe and the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and focuses on off-patent oncological on·col·o·gy n. The branch of medicine that deals with tumors, including study of their development, diagnosis, treatment, and prevention. [Greek onkos, mass, tumor; see nek- pharmaceuticals. For more information, visit the company's Web site, www.bgmr.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion